Kymera Therapeutics Inc <KYMR.O>: Deutsche Bank initiates coverage with hold rating and target price $120
KYMR•Related News
HNI Q2 sales and adjusted EPS beat analyst expectations
HNI•
Real Brokerage expands Northern Virginia footprint as Chris Colgan Team joins with 28 agents, $150 million annual volume
REAX•
Catalyst Bancorp Q2 net interest margin rises
CLST•
Netlist swings to Q2 FY26 net income of $1.4 million; net sales more than doubled to $109.8 million
NLST•
Lincoln Electric Q2 sales rise 12%, beat estimates
LECO•